Sittner & Nelson’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Sittner & Nelson's GILD Position: Q1 2026 in Review
Sittner & Nelson held its Gilead Sciences (GILD) position steady in Q1 2026 at 8,200 shares worth $1.14M. The position accounts for 0.42% of the portfolio, ranked #56.
Sittner & Nelson first reported a position in GILD in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.25M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Sittner & Nelson held 8,200 shares of Gilead Sciences worth $1.14M as of Q1 2026.
- Sittner & Nelson left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.42% of Sittner & Nelson's portfolio in Q1 2026, its #56 holding.
- Sittner & Nelson first reported a position in Gilead Sciences in Q4 2020 and has held it in 22 quarters since.
- Sittner & Nelson's Gilead Sciences position peaked at $1.25M in Q4 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Sittner & Nelson's 13F filing for Q1 2026, filed 12 May 2026.